title: Intensified glucose control in type 2 diabetes--whose agenda?
authors.affiliation: University College London, London WC1E 6BT, UK. j.yudkin@ucl.ac.uk
authors.forename: John S
authors.initials: JS
authors.lastname: Yudkin
authors.forename: Bernd
authors.initials: B
authors.lastname: Richter
authors.forename: Edwin A M
authors.initials: EA
authors.lastname: Gale
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D015190:Blood Glucose Self-Monitoring; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control*; D048909:Diabetes Complications / Q000097:blood / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004345:Drug Industry; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000191:economics; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012109:Research Support as Topic; D006113:United Kingdom; D014481:United States
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents